Format

Send to

Choose Destination
Neuro Oncol. 2019 Jan 1;21(1):125-136. doi: 10.1093/neuonc/noy094.

Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.

Author information

1
Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
2
Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.
3
Unit of Statistics and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark.
4
Department of Clinical Sciences, Lund University, Pediatric Oncology and Hematology, Skåne University Hospital, Lund, Sweden.
5
The Icelandic Cancer Registry, Reykjavik, Iceland.
6
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
7
The Finnish Cancer Registry, Helsinki, Finland.
8
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
9
Research Management and Administration, Danish Cancer Society Research Center, Copenhagen, Denmark.

Abstract

Background:

A comprehensive overview of neurologic complications among survivors of central nervous system (CNS) tumors in childhood is lacking. We aimed to investigate the risk for these disorders in a large, population-based study with outcome measures from nationwide hospital registries.

Methods:

We identified 4858 five-year survivors with diagnoses of CNS tumor in childhood in Denmark, Iceland, Finland, and Sweden in 1943-2007, and 166658 matched population comparison subjects. Inpatient discharge diagnoses of neurologic disorders were used to calculate relative risks (RRs) and absolute excess risks (AERs).

Results:

A neurologic disorder was verified in 1309 survivors, while 92.4 were expected, yielding an overall RR of 14.2 (95% confidence interval [CI]: 13.3-15.1) and an AER of 20 hospitalizations per 1000 persons per year. The risks remained increased more than 20 years after diagnosis (RR: 6.3, 95% CI: 5.6-7.2; AER: 11, 9-12). The most frequent diagnoses were epilepsy (affecting 14.1% of all survivors) followed by hydrocephalus (9.5%) and paralytic syndromes (4.2%), with RRs of 28.7 (95% CI: 26.0-31.6), 243 (95% CI: 190-311), and 40.3 (95% CI: 33.1-49.2), respectively. Of these outcomes, 30%-40% were diagnosed prior to or synchronously with the CNS tumor. The survivors had highly increased RRs for infectious diseases of the CNS, disorders of cranial nerves, and degenerative diseases of the nervous system.

Conclusions:

Survivors of childhood CNS tumors are at markedly increased risk for neurologic disorders throughout their lives. Health care professionals must be aware of survivors who might benefit from preventive interventions and intensive follow-up.

PMID:
29850875
PMCID:
PMC6303468
[Available on 2020-01-01]
DOI:
10.1093/neuonc/noy094

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center